Synergism between Angiotensin receptors ligands: Role of Angiotensin-(1-7) in modulating AT

Angiotensin I / administration & dosage Angiotensin II / administration & dosage Cell Line Dose-Response Relationship, Drug Drug Synergism Humans Kidney / cytology Ligands Nitric Oxide / metabolism Peptide Fragments / administration & dosage Proto-Oncogene Mas Proto-Oncogene Proteins / agonists Receptor, Angiotensin, Type 2 / agonists Receptors, G-Protein-Coupled / agonists
angiotensin receptor epithelial cells nitric oxide receptor mas synergism

Journal

Pharmacology research & perspectives
ISSN: 2052-1707
Titre abrégé: Pharmacol Res Perspect
Pays: United States
ID NLM: 101626369

Informations de publication

Date de publication:
12 2020
Historique:
received: 10 07 2020
revised: 14 09 2020
accepted: 15 09 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 4 9 2021
Statut: ppublish

Résumé

Angiotensin-(1-7), an endogenous agonist for the MasR, has been shown to interact with ang-II AT

Identifiants

DOI: 10.1002/prp2.667 PMID: 33197136 PMC: PMC7668194
pubmed: 33197136
doi: 10.1002/prp2.667
pmc: PMC7668194
doi:

Substances chimiques

Ligands 0
MAS1 protein, human 0
Peptide Fragments 0
Proto-Oncogene Mas 0
Proto-Oncogene Proteins 0
Receptor, Angiotensin, Type 2 0
Receptors, G-Protein-Coupled 0
Angiotensin II 11128-99-7
Nitric Oxide 31C4KY9ESH
Angiotensin I 9041-90-1
angiotensin I (1-7) IJ3FUK8MOF

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e00667

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK061578
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK117495
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK061578
Pays : United States
Organisme : NIDDK NIH HHS
ID : DK117495
Pays : United States

Informations de copyright

© 2020 The Authors. Pharmacology Research & Perspectives published by John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics.

Références

Pulm Circ. 2015 Dec;5(4):649-57
pubmed: 26697172
Kidney Int. 2013 Nov;84(5):931-9
pubmed: 23823602
Front Pharmacol. 2018 Aug 21;9:928
pubmed: 30186168
Circ Res. 2000 Jun 23;86(12):1266-72
pubmed: 10864918
PLoS One. 2019 Nov 25;14(11):e0224137
pubmed: 31765385
Clin Sci (Lond). 2010 Feb;118(4):291-301
pubmed: 19728860
Am J Physiol Renal Physiol. 2010 Jan;298(1):F37-48
pubmed: 19846569
Hypertens Res. 2012 Jun;35(6):654-60
pubmed: 22297475
EMBO J. 2000 Aug 1;19(15):4026-35
pubmed: 10921883
Curr Hypertens Rep. 2018 May 1;20(5):41
pubmed: 29717388
Nat Methods. 2015 Jul;12(7):661-663
pubmed: 26030448
Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F440-F449
pubmed: 28468964
Regul Pept. 2002 Jan 15;103(1):17-22
pubmed: 11738244
Hypertension. 2017 Jun;69(6):1128-1135
pubmed: 28461604
Nitric Oxide. 2014 Feb 15;37:11-6
pubmed: 24361899
Biophys J. 1999 Jun;76(6):3031-43
pubmed: 10354429
Bioinformatics. 2017 Aug 1;33(15):2413-2415
pubmed: 28379339
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106
pubmed: 29149325
Hypertension. 2005 Oct;46(4):937-42
pubmed: 16157793
Biochem J. 2006 Apr 1;395(1):183-90
pubmed: 16390332
Am J Physiol. 1996 Jan;270(1 Pt 2):F141-7
pubmed: 8769832
Anal Methods. 2014 Jan 21;6(1):215-222
pubmed: 24489613
Hypertension. 1994 Oct;24(4):457-60
pubmed: 8088911
Hypertension. 2017 Oct;70(4):831-838
pubmed: 28827476
Regul Pept. 1999 Oct 22;84(1-3):51-4
pubmed: 10535408
Peptides. 2002 Jan;23(1):57-64
pubmed: 11814618
Hypertension. 2011 Aug;58(2):176-81
pubmed: 21670420
Basic Res Cardiol. 2015 May;110(3):21
pubmed: 25804308
Nephron Exp Nephrol. 2010;116(3):e53-61
pubmed: 20616569
J Biol Chem. 2005 May 6;280(18):18237-44
pubmed: 15746093
Circ Res. 1999 Apr 30;84(8):876-82
pubmed: 10222333
Hypertension. 1995 Jul;26(1):164-70
pubmed: 7607720
Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1379-85
pubmed: 25855512
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
Circulation. 2005 May 24;111(20):2605-10
pubmed: 15897343
Pharmacol Res Perspect. 2015 Jun;3(3):e00149
pubmed: 26171228
Front Pharmacol. 2015 Sep 01;6:181
pubmed: 26388771
Cell Signal. 2011 Nov;23(11):1767-76
pubmed: 21740964
Pharmacol Rev. 2006 Sep;58(3):621-81
pubmed: 16968952
Biochem Biophys Res Commun. 2010 Jan 1;391(1):85-90
pubmed: 19896468
Nucleic Acids Res. 2020 Jul 2;48(W1):W488-W493
pubmed: 32246720
Br J Pharmacol. 2019 Dec;176 Suppl 1:S21-S141
pubmed: 31710717
Kidney Int. 2000 Dec;58(6):2437-51
pubmed: 11115077
Arch Biochem Biophys. 2010 Apr 15;496(2):117-22
pubmed: 20153712
Sci Rep. 2017 Sep 19;7(1):11903
pubmed: 28928410
Circulation. 2005 Apr 12;111(14):1806-13
pubmed: 15809376
J Am Soc Nephrol. 1994 Oct;5(4):1133-8
pubmed: 7849254
Hypertension. 2016 Dec;68(6):1365-1374
pubmed: 27698068
Biochim Biophys Acta. 2000 Jul 31;1467(1):189-97
pubmed: 10930521
J Biol Chem. 2001 Oct 26;276(43):39721-6
pubmed: 11507095
Am J Physiol. 1998 Jan;274(1):C214-20
pubmed: 9458730
Am J Physiol Renal Physiol. 2012 Apr 1;302(7):F875-83
pubmed: 22218590
Regul Pept. 2009 Jun 5;155(1-3):81-90
pubmed: 19345245

Auteurs

Sanket Patel (S)

Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA.
ORCID: 0000-0003-1674-711X

Tahir Hussain (T)

Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Autacoïdes › Angiotensines › Angiotensine-I › Synergism between Angiotensin receptors...
questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Autacoïdes › Angiotensines › Angiotensine-II › Synergism between Angiotensin receptors...
questionsmedicales.fr › Cellules › Cellules cultivées › Lignée cellulaire › Synergism between Angiotensin receptors...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes toxicologiques › Relation dose-effet des médicaments › Synergism between Angiotensin receptors...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Interactions médicamenteuses › Synergie des médicaments › Synergism between Angiotensin receptors...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Synergism between Angiotensin receptors...
questionsmedicales.fr › Appareil urogénital › Voies urinaires › Rein › Synergism between Angiotensin receptors...
questionsmedicales.fr › Actions chimiques et utilisations › Utilisations spécialisées de produits chimiques › Produits chimiques de laboratoire › Ligands › Synergism between Angiotensin receptors...
questionsmedicales.fr › Produits chimiques inorganiques › Composés de l'oxygène › Oxydes › Oxydes d'azote › Monoxyde d'azote › Synergism between Angiotensin receptors...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Fragments peptidiques › Synergism between Angiotensin receptors...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Proto-oncogène Mas › Synergism between Angiotensin receptors...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Synergism between Angiotensin receptors...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteurs aux angiotensines › Récepteur de type 2 à l'angiotensine-II › Synergism between Angiotensin receptors...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs couplés aux protéines G › Synergism between Angiotensin receptors...